USC Norris Comprehensive Cancer Center

An NCI-designated Comprehensive Cancer Center

DONATE

Leadership

Senior Leadership

Screen Shot 2020-11-03 at 2.44.23 PM

Caryn Lerman, PhD

Director, USC Norris Comprehensive Cancer Center

Anest

Vasiliki Anest, PhD

Chief Innovation Officer

Lourdes Baezconde-Garbanati earns AACR Distinguished Lectureship

Lourdes Baezconde-Garbanati, MPH, PhD

Associate Director,
Community Outreach & Engagement

John Carpten, PhD

Associate Director, Basic Research

David Conti, PhD

Associate Director, Data Science

Yves DeClerck, MD

Associate Director, Cancer Research Training and Education

Anthony

Anthony B. El-Khoueiry, MD

Associate Director, Clinical Research

Chanita

Chanita Hughes-Halbert, PhD

Associate Director, Cancer Equity

Amir

Amir Goldkorn, MD

Associate Director, Translational Research

grossman news

Steven Grossman, MD, PhD

Deputy Director for Cancer Services

Lenz 3

Heinz-Josef Lenz, MD

Deputy Director for Research Programs

Chris

Christopher Loertscher, MA

Associate Director for Administration & Chief Administrative Officer

Stern

Mariana Stern, PhD

Associate Director, Population Science

190x220-jennifer-tsui

Jennifer Tsui, PhD

Director for Cancer Care Delivery Research and Implementation Science (CCD/IS)

Alan S. Wayne, MD

Associate Director, Pediatric Oncology

Joseph Wiemels, PhD

Associate Director, Shared Resources

Program Leaders

Genomic and Epigenomic Regulation

The program is led by Bodour Salhia, PhD, a translational genomics scientist with extensive knowledge and expertise in mechanisms that underlie tumorigenesis and tumor biology, and Yali Dou, PhD, known for translation of epigenetic discoveries into novel inhibitors.

Bodour Salhia, PhD

Co-Leader

Yali Dou

Yali Dou, PhD

Co-Leader

Tumor Microenvironment

The program leader W. Martin Kast, PhD  has recognized expertise in cancer virology, cancer immunology, and cancer immunotherapy.

W. Martin Kast, PhD

Leader

Translational and Clinical Sciences

The program co-leaders Heinz-Josef Lenz, MD and Fumito Ito, MD, PhD have complementary recognized expertise in cancer genomics, drug target discovery, drug development, and translational research and clinical trials.

Heinz-Josef Lenz, MD

Co-Leader

Fumito Ito, MD, PhD

Co-Leader

Cancer Epidemiology

The program co-leaders, Wendy Setiawan, PhD, and Christopher Haiman, ScD, have complementary recognized expertise in cancer epidemiology and genetics, and immunology, biomarkers and biobanking, respectively.

Wendy Setiawan, PhD

Co-Leader

Christopher A. Haiman, ScD

Co-Leader

Cancer Control Research

The program co-leaders, Myles Cockburn, PhD, and Jennifer Unger, PhD, have complementary recognized expertise in cancer prevention and cancer survivorship.

Myles Cockburn, PhD

Co-Leader

Jennifer Unger, PhD

Co-Leader